Metabolomic profiling has emerged as a powerful tool in understanding the molecular intricacies of various diseases, including Endometrial Cancer (EC) and hyperplasia. This article explores recent advancements in metabolomic profiling of blood plasma in females with hyperplasia and EC, highlighting the potential of metabolomics in early detection, prognosis and personalized treatment strategies for these conditions.
HTML PDFShare this article
Medicinal Chemistry received 6627 citations as per Google Scholar report
